Introducing TrialNet’s T1D Heroes Academy —a global alliance of type 1 diabetes (T1D) superheroes beckoned to the front lines of scientific research to benefit all humanity. These mighty and courageous heroes rise against adversity to benefit the greater good by participating in TrialNet’s free risk screening program and clinical trials.
Join the UF Diabetes Institute for a seminar on November 14th from 12:00-1:00 p.m. Kathryn M. Ross., Ph.D., M.P.H., is an Associate Professor in the Department of Clinical & Health Psychology at the University of Florida. The seminar title is “Leveraging Technology to Improve Access to Behavioral Interventions for Obesity”.
2021 marks the 100th year since Sir Frederick Banting, Charles Best, and Professor John Macleod from the University of Toronto reported the successful treatment of canine diabetes with a pancreas extract, now known as insulin. This discovery represented not only a remarkable scientific achievement, but more importantly, provided a life-saving…
Do you or your child have Type 1 Diabetes? Are you wondering if other members of your family, adults or children, may be at risk for developing T1D? Is there a way to screen for that? If they are at risk, is there anything that can be done to delay…
State of the Science is an interactive conversation with room for granular and lively debate focused on the most pressing issues in type 1 diabetes (T1D) research. Our goal is to foster open science, interaction, and collaboration–all hallmarks of the(sugar)science mission. These virtual conversations will involve: 30 minute introduction – What’s…
Reposted from UF Office of Research, Written by Jill Pease “The hungrier parents are at mealtimes, a new study shows, the more they may feed their young children, which could have implications for childhood obesity…”…
You and I need to turn up the heat. Together, we need to bring awareness of diabetes to the forefront of society. We need to kindle support for advocacy, education and research until our society takes note and takes action. We need to make sure that diabetes is highly visible,…
In this video exclusive, Anastasia Albanese-O’Neill, PhD, ARNP, CDE, assistant professor in the College of Nursing at the University of Florida Health, discusses the American Diabetes Association’s Safe at School campaign that began in 2004 to ensure that all children with type 1 diabetes are medically safe at school.
UFDI investigators and collaborators found that thyroid hormone may play a role in the regulation of hepatic steatosis and support the notion that hypothyroidism may be associated with non-alcoholic fatty liver disease in patients with type 2 diabetes.
UF Investigators Colette Meehan, M.D., Janet Silverstein, M.D. examined treatment options available for youth with type 2 diabetes.
